Peregrine Capital Management LLC Axonics, Inc. Transaction History

Peregrine Capital Management LLC

$3.18 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$56.67 - $69.36 $2.49 Million - $3.04 Million	-43,877 Reduced 25.87%	125,752 $8.67 Million
Q4 2023 Jan 26, 2024	SELL	$49.38 - $63.75 $1.44 Million - $1.86 Million	-29,234 Reduced 14.7%	169,629 $10.6 Million
Q3 2023 Oct 19, 2023	SELL	$48.64 - $62.51 $1.76 Million - $2.26 Million	-36,110 Reduced 15.37%	198,863 $11.2 Million
Q2 2023 Jul 26, 2023	BUY	$47.99 - $60.21 $20,827 - $26,131	434 Added 0.19%	234,973 $11.9 Million
Q1 2023 Apr 26, 2023	BUY	$52.6 - $67.34 $1.44 Million - $1.85 Million	27,456 Added 13.26%	234,539 $12.8 Million
Q4 2022 Jan 10, 2023	BUY	$59.56 - $76.6 $1.39 Million - $1.79 Million	23,393 Added 12.74%	207,083 $12.9 Million
Q3 2022 Oct 26, 2022	SELL	$57.96 - $78.12 $3.2 Million - $4.32 Million	-55,272 Reduced 23.13%	183,690 $12.9 Million
Q2 2022 Jul 20, 2022	SELL	$39.5 - $64.42 $62,647 - $102,170	-1,586 Reduced 0.66%	238,962 $13.5 Million
Q1 2022 Apr 27, 2022	SELL	$43.74 - $62.76 $3.38 Million - $4.84 Million	-77,161 Reduced 24.29%	240,548 $15.1 Million
Q4 2021 Jan 31, 2022	BUY	$50.01 - $73.35 $1.11 Million - $1.63 Million	22,220 Added 7.52%	317,709 $17.8 Million
Q3 2021 Nov 02, 2021	SELL	$59.21 - $78.66 $5.75 Million - $7.64 Million	-97,189 Reduced 24.75%	295,489 $19.2 Million
Q2 2021 Aug 03, 2021	SELL	$51.39 - $66.9 $1.08 Million - $1.4 Million	-20,949 Reduced 5.06%	392,678 $24.9 Million
Q1 2021 May 11, 2021	SELL	$49.14 - $59.89 $2.84 Million - $3.46 Million	-57,728 Reduced 12.25%	413,627 $24.8 Million
Q4 2020 Jan 19, 2021	SELL	$42.19 - $51.5 $2.05 Million - $2.5 Million	-48,538 Reduced 9.34%	471,355 $23.5 Million
Q3 2020 Oct 20, 2020	SELL	$35.33 - $51.04 $1.75 Million - $2.53 Million	-49,602 Reduced 8.71%	519,893 $26.5 Million
Q2 2020 Jul 30, 2020	SELL	$22.91 - $39.83 $64,972 - $112,957	-2,836 Reduced 0.5%	569,495 $20 Million
Q1 2020 Apr 17, 2020	SELL	$16.44 - $37.73 $677,163 - $1.55 Million	-41,190 Reduced 6.71%	572,331 $14.5 Million
Q4 2019 Jan 16, 2020	BUY	$19.57 - $28.96 $12 Million - $17.8 Million	613,521 New	613,521 $17 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.34M
Shares

$308 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.18M
Shares

$155 Million
6.99% of portfolio
Fil LTD Hamilton, D0

2.04M
Shares

$145 Million
0.14% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.45M
Shares

$103 Million
4.89% of portfolio

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account